Independent predictors included tumor burden score > 2.4 (HR = 2.40, p = 0.003), metabolic abnormalities ≥ 2 (HR = 1.49, p = 0.023), aspartate transaminase/alanine transaminase ratio > 1 (HR = 1.51, p = 0.012), albumin-bilirubin grade 2 (HR = 1.70, p = 0.020), arterial rim enhancement (HR = 1.87, p = 0.002) and mosaic appearance (HR = 1.55, p = 0.033). Here, ALB is linked to neoplasm.